Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural and Genetic Correlates of Escitalopram Response in MDD
NCT01251471Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Medical University of Vienna. Started Aug 2011; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01251471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251471.